Vincent Giacalone, DPM
Foot & Ankle Surgery · Emerson, NJNPI 1285637025
Payments from drug & device makers
Across 334 payments — averaging $445.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$60K
- Paratek Pharmaceuticals, Inc.$50K
- Organogenesis Inc.$16K
- Royal Biologics, Inc.$15K
- Orpyx Medical Technologies Inc.$2K
- Smith+Nephew$1K
- plus $4K from 33 others
Across 8 payments — averaging $198.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 67 | $59,792 |
| Paratek Pharmaceuticals, Inc. | 95 | $50,125 |
| Organogenesis Inc. | 41 | $15,679 |
| Royal Biologics, Inc. | 2 | $15,345 |
| Orpyx Medical Technologies Inc. | 1 | $2,000 |
| Smith+Nephew | 39 | $1,384 |
| Tactile Systems Technology Inc | 12 | $661 |
| Kerecis Limited | 4 | $527 |
| Integra Lifesciences Corporation | 11 | $480 |
| Stryker | 5 | $397 |
| Treace Medical Concepts, Inc. | 7 | $361 |
| Urgo Medical North America, LLC | 4 | $226 |
| DJO, LLC | 2 | $218 |
| Averitas Pharma Inc. | 4 | $201 |
| GRT US Holding, Inc. | 3 | $152 |
| Amgen | 3 | $152 |
| Abbott | 1 | $140 |
| Nevro Corp. | 1 | $135 |
| Endo USA, Inc. | 1 | $80 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $73 |
| Zimmer Biomet | 2 | $68 |
| Boston Scientific | 1 | $63 |
| AbbVie | 4 | $55 |
| Vaporox, Inc. | 1 | $47 |
| Orthofix Medical, Inc. | 2 | $45 |
| Next Science LLC | 1 | $42 |
| Convatec Inc. | 2 | $38 |
| Fidia Pharma USA Inc. | 1 | $35 |
| Medtronic | 2 | $35 |
| Inari Medical, Inc. | 1 | $34 |
| Cardiovascular Systems Inc. | 1 | $31 |
| Resmed Corp | 1 | $30 |
| Zimvie Inc. | 1 | $29 |
| KCI USA, Inc. | 1 | $18 |
| Hydrofera LLC | 1 | $18 |
| Hartmann USA, Inc. | 1 | $17 |
| Orpyx Medical Technologies US Inc. | 1 | $16 |
| Paragon 28, Inc. | 1 | $12 |
| Cashflow Solutions, LLC | 1 | $9 |
How this compares
$148,770 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Emerson
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.